PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,701 stories, page 754 of 779

Advanced search
🇩🇪Researchhelmholtz-hips.deTier 2 · Direct publisher

Phyton Biotech Successfully Completes Corallopyronin A Technology Transfer

HIPS Helmholtz PharmaOriginal source
🇩🇪Researchhelmholtz-hips.deTier 2 · Direct publisher

Parkinson's drug as basis for new anti-infectives

HIPS Helmholtz PharmaOriginal source
🇩🇪Researchhelmholtz-hips.deTier 2 · Direct publisher

No entry: Blocking viruses from entering cells

HIPS Helmholtz PharmaOriginal source
🇩🇪Researchhelmholtz-hips.deTier 2 · Direct publisher

New platform for the production of versatile active ingredients

HIPS Helmholtz PharmaOriginal source
🇩🇪Researchhelmholtz-hips.deTier 2 · Direct publisher

New natural products against tuberculosis

HIPS Helmholtz PharmaOriginal source
🇩🇪Researchhelmholtz-hips.deTier 2 · Direct publisher

New compound cuts off protein supply to parasites

HIPS Helmholtz PharmaOriginal source
🇩🇪Researchhelmholtz-hips.deTier 2 · Direct publisher

Mannich Medal for Rolf Müller

HIPS Helmholtz PharmaOriginal source
🇩🇪Researchhelmholtz-hips.deTier 2 · Direct publisher

International Consortium Against Antimicrobial Resistance

HIPS Helmholtz PharmaOriginal source
🇩🇪Researchhelmholtz-hips.deTier 2 · Direct publisher

HIPS and Beiersdorf AG join forces in microbiome research

HIPS Helmholtz PharmaOriginal source
🇩🇪Researchhelmholtz-hips.deTier 2 · Direct publisher

HIPS Ahoy!

HIPS Helmholtz PharmaOriginal source
🇩🇪Researchhelmholtz-hips.deTier 2 · Direct publisher

Helmholtz Global Fellow at HIPS

HIPS Helmholtz PharmaOriginal source
🇩🇪Researchhelmholtz-hips.deTier 2 · Direct publisher

Comeback of the Biphenomycins

HIPS Helmholtz PharmaOriginal source
🇩🇪Researchhelmholtz-hips.deTier 2 · Direct publisher

Biodiversity as the Basis for New Drugs

HIPS Helmholtz PharmaOriginal source
🇩🇪Researchhelmholtz-hips.deTier 2 · Direct publisher

Artificial Intelligence Aids in the Development of New Active Ingredients

HIPS Helmholtz PharmaOriginal source
🇩🇪Researchhelmholtz-hips.deTier 2 · Direct publisher

A New Mechanism of Action Against an Old Enemy

HIPS Helmholtz PharmaOriginal source
🇩🇪Researchhelmholtz-hips.deTier 2 · Direct publisher

News & Events | HIPS

HIPS Helmholtz PharmaOriginal source
🇸🇪Industryhansabiopharma.comTier 1 · Company source

Hansa Biopharma to participate in Virtual US Bancorp / BTIG Kidney Health Forum

Hansa BiopharmaOriginal source
🇸🇪Industryhansabiopharma.comTier 1 · Company source

Hansa Biopharma to participate in 26th Annual Biotech in Europe Forum | Hansa Biopharma

Hansa BiopharmaOriginal source
🇸🇪Industryhansabiopharma.comTier 1 · Company source

Hansa Biopharma Partners with Cradle to Advance AI-Driven Protein Design and Engineering

Hansa BiopharmaOriginal source
🇸🇪Industryhansabiopharma.comTier 1 · Company source

Hansa Biopharma announces submission of IND Application to US FDA for HNSA-5487 in GBS

Hansa BiopharmaOriginal source
🇸🇪Industryhansabiopharma.comTier 1 · Company source

Hansa Biopharma announces positive Idefirix PAES results presented in the High-Impact Clinical Trials session at ASN Kidney Week

Hansa BiopharmaOriginal source
🇸🇪Industryhansabiopharma.comTier 1 · Company source

Hansa Biopharma Announces New Board Appointments | Hansa Biopharma

Hansa BiopharmaOriginal source
🇸🇪Industryhansabiopharma.comTier 1 · Company source

Hansa Biopharma announces Idefirix PAES late-breaking abstract selected for oral presentation in High-Impact Clinical Trials session at ASN Kidney Week

Hansa BiopharmaOriginal source
🇸🇪Industryhansabiopharma.comTier 1 · Company source

Bulletin from the Extraordinary General Meeting in Hansa Biopharma AB (publ) | Hansa Biopharma

Hansa BiopharmaOriginal source
🇯🇵Industryhamamatsu.comTier 1 · Company source

Development of the iPHEMOS®-DDX Inverted emission microscope for failure analysis of advanced semiconductor packages

Hamamatsu (NDP AI)Original source
🇯🇵Industryhamamatsu.comTier 1 · Company source

Products & technologies | Hamamatsu Photonics

Hamamatsu (NDP AI)Original source
🇯🇵Industryhamamatsu.comTier 1 · Company source

All news | Hamamatsu Photonics

Hamamatsu (NDP AI)Original source
🇯🇵Industryhamamatsu.comTier 1 · Company source

Investor relations | Hamamatsu Photonics

Hamamatsu (NDP AI)Original source
🇯🇵Industryhamamatsu.comTier 1 · Company source

Featured products & technologies | Hamamatsu Photonics

Hamamatsu (NDP AI)Original source
🇯🇵Industryhamamatsu.comTier 1 · Company source

Successfully developed world-class 2.0 kW Laser Diode bar

Hamamatsu (NDP AI)Original source
🇯🇵Industryhamamatsu.comTier 1 · Company source

Establish a subsidiary in Singapore | Hamamatsu Photonics

Hamamatsu (NDP AI)Original source
🇯🇵Industryhamamatsu.comTier 1 · Company source

Hamamatsu Photonics and RIKEN sign framework agreement on collaboration | Hamamatsu Photonics

Hamamatsu (NDP AI)Original source
🇯🇵Industryhamamatsu.comTier 1 · Company source

Sakura Finetek and Hamamatsu Photonics K.K. Global Alliance | Hamamatsu Photonics

Hamamatsu (NDP AI)Original source
🇸🇪Researchgu.seTier 2 · Direct publisher

Find news

University of GothenburgOriginal source
🇸🇪Researchgu.seTier 2 · Direct publisher

Find event

University of GothenburgOriginal source
🇸🇪Researchgu.seTier 2 · Direct publisher

Strategic research areas

University of GothenburgOriginal source
🇸🇪Researchgu.seTier 2 · Direct publisher

Research infrastructure

University of GothenburgOriginal source
🇸🇪Researchgu.seTier 2 · Direct publisher

Animal research at the University of Gothenburg

University of GothenburgOriginal source
🇸🇪Researchgu.seTier 2 · Direct publisher

Research ethics

University of GothenburgOriginal source
🇸🇪Researchgu.seTier 2 · Direct publisher

Research in sustainability and the environment

University of GothenburgOriginal source
🇸🇪Researchgu.seTier 2 · Direct publisher

Research in society and economics

University of GothenburgOriginal source
🇸🇪Researchgu.seTier 2 · Direct publisher

Research in science and information technology

University of GothenburgOriginal source
🇸🇪Researchgu.seTier 2 · Direct publisher

Research in health and medicine

University of GothenburgOriginal source
🇸🇪Researchgu.seTier 2 · Direct publisher

Research in education and learning

University of GothenburgOriginal source
🇸🇪Researchgu.seTier 2 · Direct publisher

Research in culture and languages

University of GothenburgOriginal source
🇸🇪Researchgu.seTier 2 · Direct publisher

Research areas at the University of Gothenburg

University of GothenburgOriginal source
🇸🇪Researchgu.seTier 2 · Direct publisher

Find research

University of GothenburgOriginal source
🇸🇪Researchgu.seTier 2 · Direct publisher

Excellent research

University of GothenburgOriginal source
🇸🇪Researchgu.seTier 2 · Direct publisher

University of Gothenburg in a troubled world

University of GothenburgOriginal source
🇸🇪Researchgu.seTier 2 · Direct publisher

Regarding the incident in the Canvas learning platform

University of GothenburgOriginal source
🇺🇸Industrygsk.comTier 3 · Secondary coverage

Respiratory, immunology and inflammation | GSK

Stiefel (GSK)Original source
🇺🇸Industrygsk.comTier 3 · Secondary coverage

Infectious diseases | GSK

Stiefel (GSK)Original source
🇺🇸Industrygsk.comTier 3 · Secondary coverage

Therapeutic areas | GSK

Stiefel (GSK)Original source
🇺🇸Industrygsk.comTier 3 · Secondary coverage

Research and development approach | GSK

Stiefel (GSK)Original source
🇺🇸Industrygsk.comTier 3 · Secondary coverage

Dr Tony Wood | GSK

Stiefel (GSK)Original source
🇺🇸Industrygsk.comTier 3 · Secondary coverage

Dr Sabine Luik | GSK

Stiefel (GSK)Original source
🇺🇸Industrygsk.comTier 3 · Secondary coverage

Dr Kaivan Khavandi | GSK

Stiefel (GSK)Original source
🇺🇸Industrygsk.comTier 3 · Secondary coverage

Dr Hesham Ahmed Abdullah | GSK

Stiefel (GSK)Original source
🇺🇸Industrygsk.comTier 3 · Secondary coverage

Dr Sanjay Gurunathan | GSK

Stiefel (GSK)Original source
🇺🇸Industrygsk.comTier 3 · Secondary coverage

Dr Christopher Austin | GSK

Stiefel (GSK)Original source